DIGITAL CURRENCY X TECHNOLOG (DCX) Fundamental Analysis & Valuation

NASDAQ:DCX • KYG4465R1377

Current stock price

2.05 USD
-0.03 (-1.44%)
Last:

This DCX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. DCX Profitability Analysis

1.1 Basic Checks

  • In the past year DCX has reported negative net income.
  • DCX had a negative operating cash flow in the past year.
DCX Yearly Net Income VS EBIT VS OCF VS FCFDCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 0 20M -20M -40M -60M -80M -100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -17.71%, DCX is in line with its industry, outperforming 48.57% of the companies in the same industry.
Industry RankSector Rank
ROA -17.71%
ROE N/A
ROIC N/A
ROA(3y)-11.49%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DCX Yearly ROA, ROE, ROICDCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 -200 -400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for DCX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DCX Yearly Profit, Operating, Gross MarginsDCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. DCX Health Analysis

2.1 Basic Checks

  • DCX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for DCX has been increased compared to 1 year ago.
  • Compared to 1 year ago, DCX has a worse debt to assets ratio.
DCX Yearly Shares OutstandingDCX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 1K 2K 3K 4K
DCX Yearly Total Debt VS Total AssetsDCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • DCX has an Altman-Z score of -3.07. This is a bad value and indicates that DCX is not financially healthy and even has some risk of bankruptcy.
  • DCX has a worse Altman-Z score (-3.07) than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -3.07
ROIC/WACCN/A
WACC4.35%
DCX Yearly LT Debt VS Equity VS FCFDCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -50M -100M -150M

2.3 Liquidity

  • DCX has a Current Ratio of 0.19. This is a bad value and indicates that DCX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.19, DCX is doing worse than 91.43% of the companies in the same industry.
  • A Quick Ratio of 0.18 indicates that DCX may have some problems paying its short term obligations.
  • DCX has a Quick ratio of 0.18. This is amonst the worse of the industry: DCX underperforms 91.43% of its industry peers.
Industry RankSector Rank
Current Ratio 0.19
Quick Ratio 0.18
DCX Yearly Current Assets VS Current LiabilitesDCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. DCX Growth Analysis

3.1 Past

  • DCX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 31.91%, which is quite impressive.
  • The Revenue for DCX has decreased by -27.08% in the past year. This is quite bad
EPS 1Y (TTM)31.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.2%
Revenue 1Y (TTM)-27.08%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-82.42%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DCX Yearly Revenue VS EstimatesDCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 5M 10M

More info and screens

Find the best growth stocksShow best growing peers

0

4. DCX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DCX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DCX Price Earnings VS Forward Price EarningsDCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DCX Per share dataDCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2K -4K -6K -8K -10K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DCX Dividend Analysis

5.1 Amount

  • DCX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DCX Fundamentals: All Metrics, Ratios and Statistics

DIGITAL CURRENCY X TECHNOLOG

NASDAQ:DCX (4/30/2026, 1:03:54 PM)

2.05

-0.03 (-1.44%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.2%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap40.10M
Revenue(TTM)7.51M
Net Income(TTM)-86.94M
AnalystsN/A
Price TargetN/A
Short Float %0.06%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.34
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-12473.02
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS0.38
BVpS-9.18
TBVpS-20.45
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -17.71%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-11.49%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.19
Quick Ratio 0.18
Altman-Z -3.07
F-Score3
WACC4.35%
ROIC/WACCN/A
Cap/Depr(3y)15.62%
Cap/Depr(5y)N/A
Cap/Sales(3y)50.62%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.91%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.08%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-82.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y35.36%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y41.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.37%
OCF growth 3YN/A
OCF growth 5YN/A

DIGITAL CURRENCY X TECHNOLOG / DCX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of DIGITAL CURRENCY X TECHNOLOG (DCX) stock?

ChartMill assigns a fundamental rating of 0 / 10 to DCX.


What is the valuation status of DIGITAL CURRENCY X TECHNOLOG (DCX) stock?

ChartMill assigns a valuation rating of 0 / 10 to DIGITAL CURRENCY X TECHNOLOG (DCX). This can be considered as Overvalued.


Can you provide the profitability details for DIGITAL CURRENCY X TECHNOLOG?

DIGITAL CURRENCY X TECHNOLOG (DCX) has a profitability rating of 0 / 10.


What is the financial health of DIGITAL CURRENCY X TECHNOLOG (DCX) stock?

The financial health rating of DIGITAL CURRENCY X TECHNOLOG (DCX) is 0 / 10.